UCLA Health has joined an important national clinical trial that uses genetic testing to match people who have acute myeloid leukemia, or AML, with new therapies. UCLA’s hospital system is the first in California to offer people the opportunity to participate. The Beat AML Master Trial will evaluate a precision-based medicine approach to treating the disease; it will allow people with the disease to have immediate access to new treatments that are currently in development without having to try more traditional approaches first. The approach could streamline a patient's course of treatment and, ultimately, save more lives.
UCLA Mattel Children’s Hospital has received two awards totaling $300,000 to fund research into treatments for various pediatric cancers: a $150,000 award from the Hyundai Hope On Wheels Foundation and a $150,000 award from Alex’s Lemonade Stand Foundation. The awards will support the work of Dr. Steven Jonas, clinical fellow in the division of pediatric hematology/oncology and trainee at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research. He is one of 40 recipients of the Hyundai Hope on Wheels Young Investigator Grant, presented during September for National Childhood Cancer Awareness month, and one of 18 recipients of this year’s Alex’s Lemonade Stand Young Investigator Grants.